(MENAFN) Sinan Ogan, who secured third place in the recent presidential election in Türkiye, has announced his endorsement of President Recep Tayyip Erdogan for the upcoming runoff vote scheduled for May 28. Addressing reporters on Monday, Ogan expressed his support for Erdogan as the candidate of the People's Alliance. He emphasized that after careful deliberation and consultations, he believed that backing Erdogan was the right decision for the country and its people.
Encouraging his supporters to rally behind Erdogan in the second round, Ogan acknowledged the significance of their decision and its potential impact on the nation. The endorsement from Ogan, who garnered a notable portion of the vote in the initial election, adds further momentum to Erdogan's campaign.
During the first round of voting held on May 14, millions of Turkish citizens cast their ballots to elect the country's president and members of the 600-seat parliament. While Erdogan's People's Alliance emerged with a majority in parliament, the presidential race now moves to a runoff between Erdogan and Kemal Kilicdaroglu, the leader of the main opposition Republican People's Party (CHP) and the joint candidate for the six-party opposition Nation Alliance.
Erdogan secured 49.52 percent of the vote in the initial round, positioning him as the frontrunner for the runoff. Kilicdaroglu followed closely behind with 44.88 percent of the vote, while Sinan Ogan of the ATA (Ancestral) Alliance received 5.17 percent of the vote. With Ogan's endorsement, Erdogan aims to consolidate his support and maintain his lead in the upcoming decisive election, which will determine the country's next president.
MENAFN23052023000045014228ID1106295844
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.